down arrow

Harbin Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009T3
CNY
3.72
0.08 (2.2%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Harbin Pharmaceutical Group Co., Ltd.
Why is Harbin Pharmaceutical Group Co., Ltd. ?
1
With a fall in Net Sales of -5.36%, the company declared Very Negative results in Mar 25
2
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 14.77% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -6.53% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Harbin Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Harbin Pharmaceutical Group Co., Ltd.
-6.53%
0.97
34.82%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.80%
EBIT Growth (5y)
47.72%
EBIT to Interest (avg)
5.31
Debt to EBITDA (avg)
1.06
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.85
Tax Ratio
20.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.92%
ROE (avg)
9.35%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.60
EV to EBIT
11.49
EV to EBITDA
8.39
EV to Capital Employed
1.61
EV to Sales
0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.02%
ROE (Latest)
10.54%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 2,518.34

CASH AND EQV(HY)

Highest at CNY 6,436.67 MM

NET SALES(Q)

Highest at CNY 4,142 MM

PRE-TAX PROFIT(Q)

Highest at CNY 271.68 MM

NET PROFIT(Q)

Highest at CNY 212.93 MM

EPS(Q)

Highest at CNY 0.08

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Here's what is working for Harbin Pharmaceutical Group Co., Ltd.
Interest Coverage Ratio
Highest at 2,518.34
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at CNY 4,142 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit
Highest at CNY 271.68 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 212.93 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 6,436.67 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."